跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,164 条关于
“IDH-mutant”
全部
3,164
临床试验
1,908
药物
370
机构
18
资讯
868
去年
FDA Approves Vorasidenib as Targeted Therapy for IDH-Mutant Gliomas
2个月前
Vorasidenib Offers Targeted Treatment for IDH-Mutant Low-Grade Gliomas
去年
European Regulators Recommend Approval of Vorasidenib for IDH-Mutant Grade 2 Glioma
10个月前
Vorasidenib Demonstrates Sustained Long-Term Efficacy in IDH-Mutant Grade 2 Glioma
8个月前
CATNON Trial Final Results Confirm Adjuvant Temozolomide Benefit in IDH-Mutant Anaplastic Glioma
去年
FDA Approves Voranigo (Vorasidenib) as First Targeted Therapy for IDH-Mutant Glioma
2年前
FDA Approves Vorasidenib (Voranigo) for IDH-Mutant Grade 2 Glioma
去年
Eflornithine Plus Lomustine Improves Survival in IDH-Mutant Anaplastic Astrocytoma
去年
FDA Approves Voranigo: First Targeted Therapy for IDH-Mutant Glioma Brain Cancer
去年
Servier to Present Case for Novel IDH-Mutant Glioma Drug Vorasidenib at EMA Review
第 1 页,共 87 页
上一页
下一页